matched study

matched study, matched control

a comparison between groups in which each subject animal is matched by a comparable animal in terms of age and all other measurable parameters. Called also matched or paired control.
References in periodicals archive ?
The accuracy of the closely matched study was 100% which replicates our research on Veterans with TBI or PTSD (wherein the accuracy was 94%).
One cannot assess the classification performance of the biomarker in the general population using only data from a matched study.
The Czech Republic study, which uses the same matched study design as our analysis, for postneonatal infant mortality gives an adjusted odds ratio of 1.
My finance manager at the Health Trust proved to be a pillar of support offering matched study leave with annual leave and a fully-funded study leave package.
Crit-Line Monitor Use in Incident Hemodialysis Patients Improves Dry Weight and Adequacy, While Reducing Epoetin Alfa Dose: A Propensity Score Matched Study (Scott Sibbel, PhD et al.
6% reduction in average monthly medical costs as compared with a matched study control group.
As part of the Phase II clinical development of MC-4232, the Company recently completed and announced positive results from the Phase II MATCHED study in patients with coexisting diabetes and hypertension.
As part of the Phase II/III clinical development of MC-4232, the Company recently completed and announced positive results from the Phase II MATCHED study in patients with coexisting diabetes and hypertension.
These two upcoming conferences are excellent forums to share the Company's recent progress, most notably positive results from the Phase II MATCHED study with MC-4232 and the recent FDA Fast Track designation for MC-1," commented Dr.
TSX:MPH)(AMEX:MCU), a cardiovascular drug discovery and development company, is pleased to announce that MC-4232 met primary blood pressure and metabolic endpoints in the Phase II MATCHED study.
TSX:MPH)(AMEX:MCU), a cardiovascular drug discovery and development company today announced it will host a conference call and webcast on Wednesday, September 14, 2005, to discuss the results from the Phase II MATCHED study.
As expected, research and development expenditures were higher as compared to the same periods in fiscal 2004 due to the ongoing Phase II/III Coronary Artery Bypass Graft (CABG) trial attributed to MC-1, called MEND-CABG and the Phase II MATCHED study with MC-4232.